Persistent Effect of IFNAR-1 Genetic Polymorphism on the Long-Term Pathogenesis of Chronic HBV Infection
Xingxing He(Wuhan University), Ju‐Sheng Lin(Tongji Hospital), Ying Chang(Wuhan University), Huajun Jiang(Union Hospital), Feng Tang(Huazhong University of Science and Technology), Peiyuan Li(Hebei Medical University), Yuhu Song(Huazhong University of Science and Technology), Qionghui Xie(Huazhong University of Science and Technology), Fanying Meng(Shanghai University)
Cited by 38
Related Papers
Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets
|Journal of Experimental & Clinical Cancer Research|2021|216
Molecular and Cellular Pharmacology of the Hypoxia-Activated Prodrug TH-302
|Molecular Cancer Therapeutics|2011|206
Tough polyacrylamide-tannic acid-kaolin adhesive hydrogels for quick hemostatic application
|Materials Science and Engineering C|2020|133
YTHDF1 promotes hepatocellular carcinoma progression via activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition
|Experimental Hematology and Oncology|2021|101
OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALL
|Clinical Cancer Research|2019|53